AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ALFUZOSINE
18 registrations across 3 African markets— 14 active
Markets with ALFUZOSINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| XAPROST LP Comprimé à libération prolongée / 10 mg | 🇹🇳Tunisia | PHARMACARE | expired | Aug 2018 |
| URITAB Comprimé à libération prolongée / 10 mg | 🇹🇳Tunisia | TABUK Pharmaceutical .M. CO | expired | Aug 2017 |
| XATRAL LP Comprimé à libération prolongée / 10 MG | 🇹🇳Tunisia | SANOFI-AVENTIS FRANCE | expired | Jul 2001 |
| XATRAL Comprimé / 2.500 MG | 🇹🇳Tunisia | SANOFI-AVENTIS FRANCE | expired | Apr 1992 |
| XATRAL LP comprimé / 10 mg | 🇸🇳Senegal | SANOFI AVENTIS | active | — |
| XATRAL LP COMPRIME LP | 🇲🇦Morocco | — | active | — |
| FLOTRAL COMPRIME LP | 🇲🇦Morocco | — | active | — |
| XATRAL comprimé pelliculé / 2.5mg | 🇸🇳Senegal | SANOFI | active | — |
| XATRAL LP COMPRIME ENROBE LP | 🇲🇦Morocco | — | active | — |
| FLOTRAL COMPRIME LP | 🇲🇦Morocco | — | active | — |
| XATRAL comprimé pelliculé / 2.5mg | 🇸🇳Senegal | SANOFI | active | — |
| XATRAL LP COMPRIME ENROBE LP | 🇲🇦Morocco | — | active | — |
| XATRAL COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| FLOTRAL COMPRIME LP | 🇲🇦Morocco | — | active | — |
| ALFA-GH comprimé LP / 10 mg | 🇸🇳Senegal | GENERIC HEALTH CARE PVT. LTD | active | — |
| FLOTRAL COMPRIME LP | 🇲🇦Morocco | — | active | — |
| XATRAL LP COMPRIME LP | 🇲🇦Morocco | — | active | — |
| XATRAL LP comprimé à libération prolongée / 5 mg | 🇸🇳Senegal | SYNTHELABO | active | — |
ALFUZOSINE in Africa — Regulatory Overview
ALFUZOSINE is registered across 3 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 14 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.